FDA Status and Safety Risks of Compounded GLP-1 Products Highlighted

A recent publication clarifies that compounded GLP-1 products are not FDA-approved finished medicines and have not undergone premarket review for safety, efficacy, or manufacturing quality. Their safety relies solely on verifying pharmacy licensure and prescription requirements, rather than federal endorsement. Insurance coverage for these compounded versions is plan-specific and not guaranteed, and selling prescription medicine without a prescription is identified as an unsafe practice. Compounded GLP-1 products from unverified online sources carry elevated risks including contamination, incorrect dosing, or counterfeit ingredients.